Comorbidity and the risk of venous thromboembolism in prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|20|3574-3576

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.20, 2015-10, pp. : 3574-3576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995‐2011

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3692-3699

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration‐resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1025-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 3, 2015-03 ,pp. : 390-397

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Venous Thromboembolism in Cancer Patients

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 66-70

Karger

Access to resources Recommend Favorite

Venous Thromboembolism as First Manifestation of Cancer

By  

Acta Haematologica, Vol. 106, Iss. 1-2, 2001-09 ,pp. : 13-17

Karger

Access to resources Recommend Favorite